FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Medical examiner releases preliminary findings in Lindsey Graham’s death as death certificate remains pending

Mitch McConnell breaks silence on mystery hospitalization after Graham’s death

From ‘disgrace’ to ‘family’: Trump’s remarkable journey with Lindsey Graham

Some Somali Kids Allegedly Spent Their July 4 Weekend Shooting People

Dr. Phil Speaks Out Against Anti-Christian Persecution

Here’s Why Judge Blocked Blue State’s Gun Ban

Father, son killed in plane crash on way home from baseball game

Graham’s death ignites GOP scramble for Senate seat as Trump hints he already has a favorite

Huckabee: Banner at Supreme Leader’s Funeral Exposes the Real Iran

Trump Spoke to Lindsay Graham Shortly Before His Death, Offers Glowing Praise for Late Republican

Report: Hours After Lindsay Graham’s Death, Nancy Mace Is Eyeing His Senate Seat

Trial of Man Accused of Lighting Infamous Los Angeles Palisades Fire Ends Inconclusively

Lindsey Graham, South Carolina senator who rose from small-town roots to GOP power broker, dies at 71

Tech Giant Dredges Up Major Player From Great Recession Saga To Be AI Watchdog

CIA’s Counter Espionage Department Investigated Unvaccinated Employees, Lawsuit Alleges

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”